Head-to-head comparison between F-FDG and F-PSMA-1007 PET/CT in diagnosing recurrent and metastatic prostate cancer.
APA
Wang N, You J, et al. (2026). Head-to-head comparison between F-FDG and F-PSMA-1007 PET/CT in diagnosing recurrent and metastatic prostate cancer.. Journal of translational medicine. https://doi.org/10.1186/s12967-026-08045-w
MLA
Wang N, et al.. "Head-to-head comparison between F-FDG and F-PSMA-1007 PET/CT in diagnosing recurrent and metastatic prostate cancer.." Journal of translational medicine, 2026.
PMID
41882728
같은 제1저자의 인용 많은 논문 (5)
- Risk factor for colorectal neoplasms: obstructive sleep apnea or nocturnal hypoxemia?
- Combination of indoline with alepterolic acid produces potent anti-breast cancer agents.
- Enhancing lipid nanoparticles-mediated RNA delivery to glioblastoma via targeted strategies.
- Denosumab Plus Immune Checkpoint Inhibitors in Bone Metastases From Solid Tumors.
- Tumor microbiome-transcriptome crosstalk identifies as an immunotherapeutic predictor in NSCLC.